Douglas J Veale Selected Research

Antirheumatic Agents (DMARD)

1/2021	COVID-19 and rheumatic musculoskeletal disease patients: infection rates, attitudes and medication adherence in an Irish population.
1/2020	EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.
11/2017	Synovial Immunophenotype and Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis Patients: Relationship to Treatment Response and Radiologic Prognosis.
1/2010	Remission in psoriatic arthritis: is it possible and how can it be predicted?
1/2002	Management of spondyloarthropathy: new pharmacological treatment options.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Douglas J Veale Research Topics

Disease

41	Rheumatoid Arthritis 11/2023 - 01/2002
26	Arthritis (Polyarthritis) 02/2024 - 01/2002
22	Inflammation (Inflammations) 02/2024 - 02/2002
19	Psoriatic Arthritis 01/2021 - 02/2003
15	Hypoxia (Hypoxemia) 05/2019 - 09/2009
12	Necrosis 01/2020 - 01/2009
8	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2019 - 08/2005
6	Synovitis 01/2020 - 11/2003
6	Fatigue 01/2018 - 01/2011
5	Rheumatic Diseases (Rheumatism) 12/2020 - 12/2013
5	Giant Cell Arteritis (Horton Disease) 01/2019 - 09/2015
5	Disease Progression 01/2018 - 09/2011
5	Pain (Aches) 10/2017 - 01/2010
4	Wounds and Injuries (Trauma) 01/2021 - 11/2011
3	Neoplasms (Cancer) 01/2021 - 01/2005
3	Arthralgia (Joint Pain) 01/2021 - 01/2017
3	Osteoarthritis 01/2020 - 01/2009
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2017 - 08/2011
2	Experimental Arthritis 02/2024 - 12/2014
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2019
2	Atherosclerosis 01/2019 - 09/2015
2	Vasculitis (Vasculitides) 12/2018 - 12/2018
2	Hyperplasia 01/2018 - 11/2003
2	Chronic Disease (Chronic Diseases) 01/2018 - 02/2002
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018 - 12/2006
2	Pulmonary Arterial Hypertension 11/2013 - 11/2013
2	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2013 - 11/2013
2	Telangiectasis (Telangiectasia) 11/2013 - 11/2013
1	Type 2 Diabetes Mellitus (MODY) 11/2023
1	Non-Radiographic Axial Spondyloarthritis 07/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023
1	COVID-19 01/2021
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2021
1	Cytopenia 10/2020
1	Insulin Resistance 01/2020

Drug/Important Bio-Agent (IBA)

15	CytokinesIBA 01/2021 - 06/2006
15	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2003
12	Proteins (Proteins, Gene)FDA Link 02/2024 - 02/2003
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2024 - 11/2003
6	AutoantibodiesIBA 11/2020 - 12/2006
6	Tumor Necrosis Factor InhibitorsIBA 10/2019 - 01/2011
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 02/2003
6	C-Reactive ProteinIBA 07/2016 - 11/2003
5	ametantrone (HAQ)IBA 07/2023 - 01/2010
5	LigandsIBA 01/2021 - 11/2010
5	Antirheumatic Agents (DMARD)IBA 01/2021 - 01/2002
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2019 - 04/2010
5	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2016 - 01/2006
5	Oxygen (Dioxygen)IBA 12/2014 - 03/2010
4	Interleukin-17 (Interleukin 17)IBA 02/2024 - 01/2009
4	MicroRNAs (MicroRNA)IBA 01/2021 - 09/2019
4	ChemokinesIBA 01/2021 - 06/2010
4	InterleukinsIBA 01/2020 - 01/2016
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 04/2010
4	Acute-Phase Proteins (Acute-Phase Protein)IBA 12/2018 - 01/2006
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 08/2011
4	Toll-Like Receptor 2IBA 01/2016 - 01/2011
4	Small Interfering RNA (siRNA)IBA 06/2015 - 07/2012
4	Messenger RNA (mRNA)IBA 12/2014 - 02/2003
3	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 02/2002
3	Oncostatin MIBA 01/2019 - 10/2006
3	EnzymesIBA 12/2018 - 11/2011
3	Factor VIII (Coagulation Factor VIII)IBA 01/2018 - 07/2012
3	Rheumatoid FactorIBA 01/2017 - 05/2007
3	Immunoglobulin G (IgG)IBA 06/2015 - 02/2011
3	Collagen Type II (Type II Collagen)IBA 04/2012 - 11/2003
3	NF-kappa B (NF-kB)IBA 09/2009 - 01/2006
2	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2020
2	Interleukin-12 (IL 12)IBA 01/2020 - 12/2018
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2020 - 12/2014
2	tofacitinibIBA 10/2019 - 12/2018
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2019 - 01/2019
2	Ustekinumab (CNTO 1275)FDA Link 12/2018 - 01/2016
2	Interleukin-23 (Interleukin 23)IBA 12/2018 - 01/2016
2	AntibodiesIBA 01/2018 - 11/2011
2	Anti-Citrullinated Protein AntibodiesIBA 11/2017 - 01/2017
2	acetyl 4-aminosalicylic acidIBA 11/2017 - 01/2017
2	Janus KinasesIBA 01/2017 - 01/2016
2	Matrix Metalloproteinases (MMPs)IBA 06/2015 - 04/2012
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 06/2013 - 07/2012
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 06/2013 - 07/2012
2	ImmunosorbentsIBA 04/2012 - 11/2011
2	Mitochondrial DNA (mtDNA)IBA 04/2012 - 08/2011
2	Interleukin-8 (Interleukin 8)IBA 02/2011 - 04/2010
2	CollagenIBA 09/2007 - 11/2003
1	Therapeutic UsesIBA 11/2023
1	Glutamate DehydrogenaseIBA 11/2023
1	CanagliflozinIBA 11/2023
1	SodiumIBA 11/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2023
1	SymportersIBA 11/2023
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 07/2023
1	TOR Serine-Threonine KinasesIBA 01/2023
1	Interferon Type IIBA 01/2023
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2020
1	GlucocorticoidsIBA 01/2020

Therapy/Procedure

20	Therapeutics 11/2023 - 02/2002
10	Biological Therapy 01/2021 - 09/2007
1	Injections 01/2020